ALNY
Alnylam Pharmaceuticals Inc.
$456.04
+$6.48(+1.44%)
63
Overall
40
Value
75
Tech
76
Quality
Market Cap
$59.82B
Volume
1.82M
52W Range
$205.87 - $495.55
Target Price
$483.54
Key Metrics Overview
| Market Cap | $59.82B | P/E Ratio | 386.47 |
| 52W High | $495.55 | 52W Low | $205.87 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 32.9% | 52W Position | 86.4% |
| Overall Score | 63 | Value Score | 40 |
| Quality Score | 76 | Technical Score | 75 |
Growth Analysis
| EPS Current Est | $1.18 | EPS Next Est | $6.71 |
| EPS Growth Est | +468.6% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALNY | $456.04 | +1.4% | 1.82M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Alnylam Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW